» Articles » PMID: 21176133

Obesity Related Methylation Changes in DNA of Peripheral Blood Leukocytes

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2010 Dec 24
PMID 21176133
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite evidence linking obesity to impaired immune function, little is known about the specific mechanisms. Because of emerging evidence that immune responses are epigenetically regulated, we hypothesized that DNA methylation changes are involved in obesity induced immune dysfunction and aimed to identify these changes.

Method: We conducted a genome wide methylation analysis on seven obese cases and seven lean controls aged 14 to 18 years from extreme ends of the obesity distribution and performed further validation of six CpG sites from six genes in 46 obese cases and 46 lean controls aged 14 to 30 years.

Results: In comparison with the lean controls, we observed one CpG site in the UBASH3A gene showing higher methylation levels and one CpG site in the TRIM3 gene showing lower methylation levels in the obese cases in both the genome wide step (P = 5 × 10(-6) and P = 2 × 10(-5) for the UBASH3A and the TRIM3 gene respectively) and the validation step (P = 0.008 and P = 0.001 for the UBASH3A and the TRIM3 gene respectively).

Conclusions: Our results provide evidence that obesity is associated with methylation changes in blood leukocyte DNA. Further studies are warranted to determine the causal direction of this relationship as well as whether such methylation changes can lead to immune dysfunction.

Citing Articles

Obesity prolongs the pro-inflammatory response and attenuates bone healing on titanium implants.

Avery D, Morandini L, Sheakley L, Alajmi A, Bergey L, Donahue H Acta Biomater. 2024; 192():473-486.

PMID: 39586347 PMC: 11735295. DOI: 10.1016/j.actbio.2024.11.040.


DNA Methylation Signatures in Paired Placenta and Umbilical Cord Samples: Relationship with Maternal Pregestational Body Mass Index and Offspring Metabolic Outcomes.

Gomez-Vilarrubla A, Mas-Pares B, Carreras-Badosa G, Bonmati-Santane A, Martinez-Calcerrada J, Niubo-Pallas M Biomedicines. 2024; 12(2).

PMID: 38397903 PMC: 10886657. DOI: 10.3390/biomedicines12020301.


Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.

Zhang N, Tian X, Yan T, Wang H, Zhang D, Lin C Front Immunol. 2023; 14:1148722.

PMID: 37020540 PMC: 10067741. DOI: 10.3389/fimmu.2023.1148722.


Improper preanalytical processes on peripheral blood compromise RNA quality and skew the transcriptional readouts of mRNA and LncRNA.

He Y, Dong L, Yi H, Zhang L, Shi X, Su L Front Genet. 2023; 13:1091685.

PMID: 36685907 PMC: 9845260. DOI: 10.3389/fgene.2022.1091685.


Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity.

Shirakawa K, Sano M Front Immunol. 2023; 13:1044737.

PMID: 36685567 PMC: 9846168. DOI: 10.3389/fimmu.2022.1044737.


References
1.
Karalis K, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T . Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J. 2009; 276(20):5747-54. DOI: 10.1111/j.1742-4658.2009.07304.x. View

2.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

3.
Smale S . The establishment and maintenance of lymphocyte identity through gene silencing. Nat Immunol. 2003; 4(7):607-15. DOI: 10.1038/ni0703-607. View

4.
Attwood J, Yung R, Richardson B . DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 2002; 59(2):241-57. PMC: 11146104. DOI: 10.1007/s00018-002-8420-z. View

5.
Ge D, Dong Y, Wang X, Treiber F, Snieder H . The Georgia Cardiovascular Twin Study: influence of genetic predisposition and chronic stress on risk for cardiovascular disease and type 2 diabetes. Twin Res Hum Genet. 2007; 9(6):965-70. DOI: 10.1375/183242706779462877. View